病毒后肺部疾病:微生物群作为关键参与者
Sabine V Stadler1, Christophe von Garnier1, Niki D Ubags1
1Division of Pulmonary Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
病毒性呼吸道感染可能导致慢性肺损伤. 这篇评论探讨了免疫反应和呼吸道细菌如何相互作用,导致病毒后肺病,突出流感,RSV和冠状病毒.
科学领域:
- 肺病学和微生物学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 病毒性呼吸道感染可以通过不清楚的免疫病理路径导致慢性肺损伤.
- 在病毒感染期间,呼吸道微生物群发生变化,可能会恶化炎症和肺损伤.
- 病毒后肺损伤涉及病毒感染,免疫反应和气道微生物群组成之间的复杂相互作用.
研究的目的:
- 审查病毒后肺损伤的临床特征.
- 阐明病毒引起的肺部疾病中的免疫病理机制和宿主细菌相互作用.
- 突出呼吸道微生物群在病毒引起的肺部瘤中的作用,并建议未来的研究方向.
主要方法:
- 文献综述侧重于临床特征,免疫病理学和宿主细菌相互作用.
- 分析涉及流感病毒,呼吸道同胞病毒和冠状病毒的研究.
- 关于气道微生物群对病毒后肺病发展的影响的综合证据.
主要成果:
- 病毒后肺损伤涉及病毒病原体,宿主免疫和微生物群落之间的复杂相互作用.
- 呼吸道微生物群的变化与病毒感染后肺损伤和炎症的进展有关.
- 流感,RSV和冠状病毒等特定病毒是这些复杂的病原体-宿主-微生物群动态的例子.
结论:
- 了解病毒感染和呼吸道微生物群之间的相互作用对于管理病毒后肺损伤至关重要.
- 对呼吸道微生物群的作用进行进一步的研究对于开发针对性治疗病毒引起的肺部疾病至关重要.
- 呼吸道微生物群是慢性肺部疾病病毒感染后病原和潜在治疗的关键因素.
更多相关视频
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
相关概念视频
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
